ICH M7(R2) Guideline on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk
Information
Type
International scientific guidelines adopted in Australia
Regulated products
Medical Devices
Topics
Prescription Medicines, Therapeutic Goods Regulation
Published
July 17, 2024
Last updated
July 17, 2024
Description
We have adopted this International Scientific Guideline - ICH M7 (R2); EMA/CHMP/ICH/83812/2013
Tags
Organization
Country / Region
Australia
License
Other (Non-Commercial)